Randomised clinical trial: safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of TAK-438 (vonoprazan), a novel potassium-competitive acid blocker, in healthy male subjects

BACKGROUND: TAK-438 (vonoprazan) is a potassium-competitive acid blocker that reversibly inhibits gastric H(+), K(+)-ATPase. AIM: To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of TAK-438 in healthy Japanese and non-Japanese men. METHODS: In two Phase I, randomised, doub...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Aliment Pharmacol Ther
Glavni autori: Jenkins, H, Sakurai, Y, Nishimura, A, Okamoto, H, Hibberd, M, Jenkins, R, Yoneyama, T, Ashida, K, Ogama, Y, Warrington, S
Format: Artigo
Jezik:Inglês
Izdano: Blackwell Publishing Ltd 2015
Teme:
Randomised Clinical Trials
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4654261/
https://ncbi.nlm.nih.gov/pubmed/25707624
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.13121
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items